Trial intelligence / Profile preview

ABACOPD Study

2012-003234-16Phase 4Terminated

Sponsor
Hannover Medical School
Start
Feb 2013
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Placebo-COD Research Private Ltd in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Hannover Medical School. Primary endpoint: Treatment failure requiring additional antibiotic therapy. Started Feb 2013; status: terminated.

02

Drugs

Placebo-COD Research Private Ltd
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2012-003234-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003234-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call